3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1-ethenyl-4-hydroxy-1,5-dimethyl-5-hexenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-(9CI) (133084-52-3)

Identification
Name:	3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1-ethenyl-4-hydroxy-1,5-dimethyl-5-hexenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-(9CI)
Synonyms:	LyngbyatoxinB
CAS:	133084-52-3
Molecular Formula:	C27H39 N3 O3
Molecular Weight:	0
InChI:	InChI=1/C27H39N3O3/c1-8-27(6,12-11-22(32)16(2)3)20-9-10-21-23-18(14-28-24(20)23)13-19(15-31)29-26(33)25(17(4)5)30(21)7/h8-10,14,17,19,22,25,28,31-32H,1-2,11-13,15H2,3-7H3,(H,29,33)
Molecular Structure:
Properties
Flash Point:	382.1°C
Boiling Point:	708.2°Cat760mmHg
Density:	1.1g/cm³
Refractive index:	1.564
Flash Point:	382.1°C
Safety Data

Other Product

3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-9-(5-methyl-4-hexenyl)-,[2S-(2R*,5R*)]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1-ethenyl-4-hydroxy-1,4,5-trimethylhexyl)-1,2,4,5,6,8-hexahydro-5-(methoxymethyl)-1-methyl-2-(1-methylethyl)-(9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1R)-1-ethenyl-5-hydroxy-1,5-dimethyl-3-hexenyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,[2S-(2R*,5S*)]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1R)-1-ethenyl-1,5-dimethyl-4-hexen-1-yl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1S)-1-ethenyl-1,5-dimethyl-4-hexen-1-yl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(4,8-dimethyl-3,7-nonadienyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,[2S-[2R*,5R*,9(E)]]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-, (2R,5R)-(9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1,1-dimethyl-2-propenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[5-[(2-aminoethyl)thio]-1-ethyl-1,5-dimethylhexyl]-1,2,4,5,6,8-hexahydro-4-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,[2S-[2R*,5R*,9(S*)]]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-, (2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-(1,1-dimethyl-2-propenyl)-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylpropyl)-,[2S-[2R*(R*),5R*]]- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9,9'-methylenebis[1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,2'S,5S,5'S)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,7-[(3,4-dihydro-2H-pyrrol-5-yl)carbonyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)- (9CI)
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-hexyl-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-9-octyl-,(2S,5S)-
3H-Pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one,9-[(1S,2S)-2,3-dihydroxy-1-(1H-indol-3-yl)propyl]-1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-,(2S,5S)-
Benzamide,N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-4-hydroxy-N-methyl-(9CI)
Benzoic acid,4-[[[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]methylamino]carbonyl]-,monosodium salt (9CI)
Cyclopenta[b][1]benzopyran-8(3H)-one,1-(1,5-dimethyl-4-hexenyl)-3a,5,6,7,9,9a-hexahydro-5-hydroxy-3a-methyl- (9CI)